Filling the need for trusted information on national health issues…

Ebola Vaccine Trial Using Ring Strategy To Launch In Guinea; Researchers Learn From Ebola Doctor Vaccinated After Needlestick Injury

CIDRAP News: Ebola ring vaccination trial set for Guinea launch
“The World Health Organization (WHO) announced today that a phase 3 trial of a Canadian-developed Ebola vaccine will launch this week in Guinea, with a ring vaccination strategy designed to test if vaccines might be useful for stamping out hot spots in outbreak settings. In a separate development involving the same vaccine, a research team from the United States reported their experience using it to try to prevent Ebola infection in a doctor who sustained a needlestick injury while treating patients in Sierra Leone. The doctor tested negative for Ebola, but the effect of the vaccine was unclear, the report said…” (Schnirring, 3/5).

CNN: Potentially historic Ebola vaccine campaign to be launched in Guinea (Botelho, 3/5).
New York Times: A Mishap Sheds Light on an Ebola Vaccine (Grady, 3/5).
Reuters: Guinea to start final trials of Ebola vaccines this week (Kelland/Miles, 3/5).
U.N. News Centre: U.N. health agency announces start of Ebola vaccine testing in worst-affected areas of Guinea (3/5).
Wall Street Journal: New Ebola Vaccine to Be Tested in Guinea (Morse, 3/5).
WHO: Ebola vaccine efficacy trial ready to launch in Guinea (3/5).

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.